Does granulocyte-macrophage colony-stimulating factor prevent bacterial translocation in rats with surgical trauma and obstructive jaundice?

被引:0
|
作者
Demirbag, Ali E. [1 ]
Turhan, Nesrin [2 ]
Ercis, Serpil [3 ]
Hamaloglu, Erhan [4 ]
机构
[1] Turkiye Yuksek Ihtisas Postgrad Res & Training Ho, Dept Gastrointestinal Surg, Ankara, Turkey
[2] Turkiye Yuksek Ihtisas Postgrad Res & Training Ho, Dept Pathol, Ankara, Turkey
[3] Hacettepe Univ, Sch Med, Dept Microbiol & Clin Microbiol, Ankara, Turkey
[4] Hacettepe Univ, Sch Med, Dept Gen Surg, Ankara, Turkey
关键词
GM-CSF; obstructive jaundice; surgical trauma; bacterial translocation; Kupffer cell; GUT BARRIER FUNCTION; INTESTINAL PERMEABILITY; INCREASES BACTERIAL; CONTROLLED-TRIAL; FAILURE; ENDOTOXIN; BLOOD; DYSFUNCTION; ACTIVATION; MICE;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/aims: The incidence of sepsis can be decreased by preventing bacterial translocation, as the first step in enhanced host defense. The aim of this study was to prevent translocation and to increase Kupffer cell incidence by using granulocyte-macrophage colony-stimulating factor in rats with surgical trauma and obstructive jaundice. Methods: Seventy-five Sprague-Dawley rats were randomized into 8 groups. After calibration of laboratory conditions by Group 0, SHAM operations in Groups I, H, HA and common bile duct ligations in Groups III, IV, IVA and V were performed. Granulocyte-macrophage colony-stimulating factor doses were 6 mu g/kg/d in Groups II, IV; 1 mu g/kg/d in HA, IVA postoperatively; and 6 mu g/kg/d in Group V preoperatively, for 7 days. After one week, all rats were reoperated for cecal lymph node, liver and spleen biopsies for culture and histopathology. All culture specimens were identified as positive/negative/contaminated. Survivals were recorded, and after the 21(st) day surviving rats were sacrificed by decapitation. Results: There was no translocation in Group 0 in the three specimens of liver, cecal lymph node and spleen. Group V showed minimal (10%) positivity in only liver, and othergroups ranged between 20-70% in cecal lymph node, liver and spleen tissues, respectively (p<0.05). Kupffer cell incidences were higher in the granulocyte-macrophage colony-stimulating factor given groups than in controls, and lower in common bile duct ligation groups than in SHAM groups (p<0.001). Groups 0 and V showed the best (median 20 days) and Group III the worst (methan 11.7 days) survival (p<0.001). Conclusions: Not only surgical trauma but also obstructive jaundice caused high incidence of translocation, decreased number of Kupffer cells and shortened survival. Translocation ratios were decreased by granulocyte-macrophage colony-stimulating factor in the SHAM and common bile duct ligation groups. Granulocyte-macrophage colony-stimulating factor prevented the decrease in Kupffer cell incidence caused by jaundice and prolonged the survival by preventing translocation at the first step.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 50 条
  • [31] PEGylated murine Granulocyte-macrophage colony-stimulating factor: Production, purification, and characterization
    Sainathan, SK
    Tu, LW
    Bishnupuri, KS
    Han, M
    Li, AG
    Newberry, RD
    McDonald, KG
    Crimmins, DL
    Houchen, C
    Anant, S
    Dieckgraefe, BK
    PROTEIN EXPRESSION AND PURIFICATION, 2005, 44 (02) : 94 - 103
  • [32] A Promising Target in Rheumatoid Arthritis Treatment: Granulocyte-Macrophage Colony-Stimulating Factor
    A. Berkant Avci
    Eugen Feist
    Gerd-R. Burmester
    Current Treatment Options in Rheumatology, 2015, 1 (4) : 320 - 333
  • [33] Response to Inhaled Granulocyte-Macrophage Colony-Stimulating Factor in a Patient With Alveolar Proteinosis
    Rodriguez Portal, Jose Antonio
    Rodriguez Becerra, Eulogio
    Sanchez Garrido, Antonio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2009, 45 (03): : 150 - 152
  • [34] Granulocyte-macrophage colony-stimulating factor promotes human blastocyst development in vitro
    Sjöblom, C
    Wikland, M
    Robertson, SA
    HUMAN REPRODUCTION, 1999, 14 (12) : 3069 - 3076
  • [35] Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain
    Cook, Andrew D.
    Pobjoy, Jarrad
    Sarros, Shannon
    Steidl, Stefan
    Duerr, Manuela
    Lacey, Derek C.
    Hamilton, John A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (02) : 265 - 270
  • [36] FUTURE USES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF)
    JONES, TC
    STEM CELLS, 1994, 12 : 229 - 240
  • [37] Differential immunostimulating effect of Granulocyte-macrophage colony-stimulating factor (GM-CSF), Granulocyte colony-stimulating factor (G-CSF) and Interferon γ (IFNγ) after severe trauma
    S. Lendemans
    E. Kreuzfelder
    C. Waydhas
    F. U. Schade
    S. Flohé
    Inflammation Research, 2007, 56 : 38 - 44
  • [38] Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
    Mu, Xiuying
    Liu, Kai
    Li, Huajie
    Wang, Fu-Sheng
    Xu, Ruonan
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (08) : 2057 - 2058
  • [39] Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis
    Ruchaud-Sparagano, Marie-Helene
    Gertig, Helen
    Hester, Katy L. M.
    Macfarlane, James G.
    Corris, Paul A.
    Simpson, A. John
    De Soyza, Anthony
    RESPIROLOGY, 2013, 18 (08) : 1230 - 1235
  • [40] Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis
    Tazawa, R
    Hamano, E
    Arai, T
    Ohta, H
    Ishimoto, O
    Uchida, K
    Watanabe, M
    Saito, J
    Takeshita, M
    Hirabayashi, Y
    Ishige, I
    Eishi, Y
    Hagiwara, K
    Ebina, M
    Inoue, Y
    Nakata, K
    Nukiwa, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (10) : 1142 - 1149